{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T02:10:01Z","timestamp":1756692601272,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1136\/ijgc-2024-005368","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T21:40:37Z","timestamp":1717623637000},"page":"1382-1388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1377-2651","authenticated-orcid":false,"given":"Utku","family":"Akg\u00f6r","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derman","family":"Basaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6763-9720","authenticated-orcid":false,"given":"Mehmet Mutlu","family":"Meydanli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Kuscu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuat","family":"Demirkiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samet","family":"Topuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffer","family":"Sanc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozgur","family":"Akbay\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4221-4459","authenticated-orcid":false,"given":"Murat","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Yavuz","family":"Salihoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5240-8441","authenticated-orcid":false,"given":"Huseyin","family":"Akilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tugan","family":"Bese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeliha","family":"F\u0131rat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamdullah","family":"Sozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nejat","family":"Ozgul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ayhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2024-005368_bb0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2024-005368_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2024-005368_bb0020","first-page":"394","article-title":"Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2024-005368_bb0025","doi-asserted-by":"crossref","first-page":"113317","DOI":"10.1016\/j.ejca.2023.113317","article-title":"Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - an international pooled analysis of three ESGO accredited centres","volume":"193","author":"Schwameis","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2024-005368_bb0030","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2024-005368_bb0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.radonc.2020.11.018","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"154","author":"Concin","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1136\/ijgc-2024-005368_bb0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2019.09.016","article-title":"LVSI positive and NX in early endometrial cancer: surgical restaging (and no further treatment if N0), or adjuvant ERT","volume":"156","author":"Harris","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005368_bb0045","article-title":"FIGO 2023 endometrial cancer staging: too much, too soon","author":"McCluggage","year":"2023","journal-title":"Int J Gynecol Cancer"},{"volume":"Vol 4","year":"2020","author":"WHO Classification of Tumours Editorial Board","key":"10.1136\/ijgc-2024-005368_bb0050"},{"key":"10.1136\/ijgc-2024-005368_bb0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2006.01.032","article-title":"Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients","volume":"101","author":"Mariani","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005368_bb0060","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2024-005368_bb0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7525-7-17","article-title":"A randomized trial of a lifestyle intervention in obese endometrial cancer survivors: quality of life outcomes and mediators of behavior change","volume":"7","author":"von Gruenigen","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1136\/ijgc-2024-005368_bb0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ygyno.2012.04.013","article-title":"Cardiovascular disease is the leading cause of death among endometrial cancer patients","volume":"126","author":"Ward","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005368_bb0075","doi-asserted-by":"crossref","first-page":"762329","DOI":"10.3389\/fonc.2021.762329","article-title":"Association of myometrial invasion with lymphovascular space invasion, lymph node metastasis, recurrence, and overall survival in endometrial cancer: a meta-analysis of 79 studies with 68,870 patients","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1136\/ijgc-2024-005368_bb0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2013.02.013","article-title":"Absolute depth of myometrial invasion in endometrial cancer is superior to the currently used cut-off value of 50","volume":"129","author":"Geels","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2024-005368_bb0085","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.4314\/ahs.v19i4.47","article-title":"The effect of myometrial invasion on prognostic factors and survival analysis in endometrial carcinoma","volume":"19","author":"Dane","year":"2019","journal-title":"Afr Health Sci"},{"key":"10.1136\/ijgc-2024-005368_bb0090","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2024-005368_bb0095","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy","volume":"119","author":"Wortman","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2024-005368_bb0100","article-title":"Association of myometrial invasion with lymphovascular space invasion, lymph node metastasis, recurrence, and overall survival in endometrial cancer: a meta-analysis of 79 studies with 68,870 patients","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1136\/ijgc-2024-005368_bb0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2024-005368_bb0110","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/ijgc-2020-001454","article-title":"Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion","volume":"30","author":"Son","year":"2020","journal-title":"Int J Gynecol Cancer"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24035503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24035503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2024-005368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T01:54:41Z","timestamp":1756691681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24035503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1048891X24035503"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2024-005368","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of adjuvant treatments and risk factors on survival in 2023 FIGO stage IIB endometrial cancer patients: Turkish Gynecologic Oncology Group Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2024-005368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}